255 related articles for article (PubMed ID: 29744893)
1. Genome-wide binding of transcription factor ZEB1 in triple-negative breast cancer cells.
Maturi V; Enroth S; Heldin CH; Moustakas A
J Cell Physiol; 2018 Oct; 233(10):7113-7127. PubMed ID: 29744893
[TBL] [Abstract][Full Text] [Related]
2. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
[TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
5. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.
Graham TR; Yacoub R; Taliaferro-Smith L; Osunkoya AO; Odero-Marah VA; Liu T; Kimbro KS; Sharma D; O'Regan RM
Breast Cancer Res Treat; 2010 Aug; 123(1):139-47. PubMed ID: 19921427
[TBL] [Abstract][Full Text] [Related]
7. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
8. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
9. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1.
Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X
Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380
[TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.
Cho HJ; Oh N; Park JH; Kim KS; Kim HK; Lee E; Hwang S; Kim SJ; Park KS
Mol Cancer Res; 2019 Nov; 17(11):2257-2266. PubMed ID: 31511359
[TBL] [Abstract][Full Text] [Related]
13. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
14. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells.
Lobert S; Graichen ME; Morris K
Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586
[TBL] [Abstract][Full Text] [Related]
15. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
[TBL] [Abstract][Full Text] [Related]
16. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
[TBL] [Abstract][Full Text] [Related]
17. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
18. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
[TBL] [Abstract][Full Text] [Related]
20. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]